Showing results (91-100 of 106) with videos related to
Sort By:
Pageof 11
Archives of Virology|November 7, 2013
Classification of HHV-6A and HHV-6B as distinct virusesDharam Ablashi, Henri Agut, Roberto Alvarez-Lafuente, et al.Mabs|June 22, 2023
Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domainYoung D Kwon, Amarendra Pegu, Eun Sung Yang, et al.Proceedings of the National Academy of Sciences of the United States of America|November 2, 2022
Anti-PF4 antibodies associated with disease severity in COVID-19Qingbo Liu, Huiyi Miao, Shuai Li, et al.AIDS Research and Therapy|July 6, 2010
Nef-specific CD45RA+ CD8+ T cells secreting MIP-1beta but not IFN-gamma are associated with nonprogressive HIV-1 infectionClaudia J Dembek, Sarah Kutscher, Silvia Heltai, et al.Science Translational Medicine|April 30, 2025
Inclusion of a retroviral protease enhances the immunogenicity of VLP-forming mRNA vaccines against HIV-1 or SARS-CoV-2 in micePeng Zhang, Mamta Singh, Vada A Becker, et al.Biorxiv : the Preprint Server for Biology|June 6, 2022
Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaquesCyril Le Nouën, Christine E Nelson, Xueqiao Liu, et al.Cell|November 24, 2022
Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeysCyril Le Nouën, Christine E Nelson, Xueqiao Liu, et al.Cell Reports|October 27, 2022
Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variantsZhaochun Chen, Peng Zhang, Yumiko Matsuoka, et al.Medrxiv : the Preprint Server for Health Sciences|January 19, 2022
Extremely potent monoclonal antibodies neutralize Omicron and other SARS-CoV-2 variantsZhaochun Chen, Peng Zhang, Yumiko Matsuoka, et al.Cell Host & Microbe|June 15, 2018
Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope TrimerPeng Zhang, Jason Gorman, Hui Geng, et al.Pageof 11